Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr 30;458(7242):1127-30.
doi: 10.1038/nature07986.

Cytoplasmic functions of the tumour suppressor p53

Affiliations
Review

Cytoplasmic functions of the tumour suppressor p53

Douglas R Green et al. Nature. .

Abstract

The principal tumour-suppressor protein, p53, accumulates in cells in response to DNA damage, oncogene activation and other stresses. It acts as a nuclear transcription factor that transactivates genes involved in apoptosis, cell cycle regulation and numerous other processes. An emerging area of research unravels additional activities of p53 in the cytoplasm, where it triggers apoptosis and inhibits autophagy. These previously unknown functions contribute to the mission of p53 as a tumour suppressor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Classification of p53 activities. On the left side, some genes that are transactivated by p53 are exemplified, together with a few of the functional consequences of p53 activation. On the right side, transactivation-independent effects of p53 are listed. These can be divided into nuclear and extranuclear (cytoplasmic) p53 activities.
Fig. 2
Fig. 2
Interplay of the nuclear and cytoplasmic functions of p53 in apoptosis. Nuclear p53 induces the expression of MDM2, which acts to inhibit the protein through binding and ubiquitinylation. Cellular stress signals interrupt this inhibition, allowing p53 to accumulate both in the nucleus and in the cytoplasm. In the latter, p53 is sequestered by anti-apoptotic Bcl-2 proteins such as Bcl-XL. Another target of nuclear p53, PUMA, functions to disrupt the Bcl-XL-p53 interaction. The released p53 can now trigger MOMP and apoptosis through interaction with, for example, Bax.
Fig. 3
Fig. 3
Concerted oncogenic actions of mutant p53 (a) or inactive ARF (b) in the nucleus and cytoplasm of cancer cells. Hot spot mutations of p53 affecting the DNA binding domain can abolish the transactivation of p53 genes as well as the mitochondrion-permeabilizing action of p53, yet leave intact autophagy inhibition by p53 (a). Similarly, oncogenic mutations that affect the C-terminus of ARF can lead to the depletion of p53 protein, as well as to the abolition of mitochondrion-permeabilizing and autophagy-inducing activities mediated by the ARF protein (b).

References

    1. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008;9:402–12. - PubMed
    1. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 1995;9:2170–83. - PubMed
    1. Kakudo Y, Shibata H, Otsuka K, Kato S, Ishioka C. Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s. Cancer Res. 2005;65:2108–14. - PubMed
    1. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 1994;370:220–3. - PubMed
    1. Chipuk JE, Maurer U, Green DR, Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell. 2003;4:371–81. - PubMed

Publication types

Substances